These include semaglutide (Wegovy) and liraglutide (Saxenda), along with newer combination agents like tirzepatide (Zepbound), which targets both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors
Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting
J Comp Physiol Psychol 84(3):488495 Gutzwiller JP, Drewe J, Gke B, Schmidt H, Rohrer B, Lareida J et al (1999) Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2
If you are seeking weight loss and are interested in using GLP-1s, be sure to have additional support for behavior and lifestyle change. Theres no denying that GLP-1s have been game-changing for many Americans struggling with weight
Whether you are on the starting dose of 0.25 mg or a higher maintenance dose, the 48-hour minimum stays the same